EKTAY
Price
$5.10
Change
-$0.12 (-2.30%)
Updated
Jun 3 closing price
Capitalization
3.09B
PHG
Price
$23.00
Change
+$0.20 (+0.88%)
Updated
Jun 4, 10:38 AM (EDT)
Capitalization
18.21B
55 days until earnings call
Interact to see
Advertisement

EKTAY vs PHG

Header iconEKTAY vs PHG Comparison
Open Charts EKTAY vs PHGBanner chart's image
Elekta AB
Price$5.10
Change-$0.12 (-2.30%)
Volume$5.33K
Capitalization3.09B
Koninklijke Philips
Price$23.00
Change+$0.20 (+0.88%)
Volume$200
Capitalization18.21B
EKTAY vs PHG Comparison Chart
Loading...
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EKTAY vs. PHG commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKTAY is a Buy and PHG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (EKTAY: $5.10 vs. PHG: $22.80)
Brand notoriety: EKTAY and PHG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EKTAY: 19% vs. PHG: 147%
Market capitalization -- EKTAY: $3.09B vs. PHG: $18.21B
EKTAY [@Medical Specialties] is valued at $3.09B. PHG’s [@Medical Specialties] market capitalization is $18.21B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKTAY’s FA Score shows that 1 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s).

  • EKTAY’s FA Score: 1 green, 4 red.
  • PHG’s FA Score: 1 green, 4 red.
According to our system of comparison, EKTAY is a better buy in the long-term than PHG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKTAY’s TA Score shows that 4 TA indicator(s) are bullish while PHG’s TA Score has 3 bullish TA indicator(s).

  • EKTAY’s TA Score: 4 bullish, 5 bearish.
  • PHG’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EKTAY is a better buy in the short-term than PHG.

Price Growth

EKTAY (@Medical Specialties) experienced а -0.97% price change this week, while PHG (@Medical Specialties) price change was -1.21% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.85%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +0.89%.

Reported Earning Dates

EKTAY is expected to report earnings on May 28, 2025.

PHG is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHG($18.2B) has a higher market cap than EKTAY($3.09B). EKTAY has higher P/E ratio than PHG: EKTAY (34.01) vs PHG (29.76). PHG YTD gains are higher at: -6.649 vs. EKTAY (-7.991). EKTAY has higher annual earnings (EBITDA): 2.49B vs. PHG (1.04B). EKTAY has more cash in the bank: 3.27B vs. PHG (1.87B). EKTAY has less debt than PHG: EKTAY (6.67B) vs PHG (7.61B). PHG has higher revenues than EKTAY: PHG (18.2B) vs EKTAY (16.9B).
EKTAYPHGEKTAY / PHG
Capitalization3.09B18.2B17%
EBITDA2.49B1.04B239%
Gain YTD-7.991-6.649120%
P/E Ratio34.0129.76114%
Revenue16.9B18.2B93%
Total Cash3.27B1.87B175%
Total Debt6.67B7.61B88%
FUNDAMENTALS RATINGS
EKTAY vs PHG: Fundamental Ratings
EKTAY
PHG
OUTLOOK RATING
1..100
2459
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6686
PRICE GROWTH RATING
1..100
6178
P/E GROWTH RATING
1..100
360
SEASONALITY SCORE
1..100
11n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKTAY's Valuation (3) in the null industry is in the same range as PHG (4) in the Electronic Production Equipment industry. This means that EKTAY’s stock grew similarly to PHG’s over the last 12 months.

EKTAY's Profit vs Risk Rating (100) in the null industry is in the same range as PHG (100) in the Electronic Production Equipment industry. This means that EKTAY’s stock grew similarly to PHG’s over the last 12 months.

EKTAY's SMR Rating (66) in the null industry is in the same range as PHG (86) in the Electronic Production Equipment industry. This means that EKTAY’s stock grew similarly to PHG’s over the last 12 months.

EKTAY's Price Growth Rating (61) in the null industry is in the same range as PHG (78) in the Electronic Production Equipment industry. This means that EKTAY’s stock grew similarly to PHG’s over the last 12 months.

EKTAY's P/E Growth Rating (3) in the null industry is somewhat better than the same rating for PHG (60) in the Electronic Production Equipment industry. This means that EKTAY’s stock grew somewhat faster than PHG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKTAYPHG
RSI
ODDS (%)
Bearish Trend 1 day ago
52%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
48%
Momentum
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 6 days ago
59%
Declines
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
61%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOXF26.351.07
+4.23%
Fox Factory Holding Corp
EQBK39.460.63
+1.62%
Equity Bancshares
CFLT23.410.35
+1.52%
Confluent
MMLP3.05-0.01
-0.33%
Martin Midstream Partners LP
FITBP23.88-0.18
-0.74%
Fifth Third Bancorp

EKTAY and

Correlation & Price change

A.I.dvisor tells us that EKTAY and SAUHY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKTAY and SAUHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKTAY
1D Price
Change %
EKTAY100%
-1.45%
SAUHY - EKTAY
31%
Poorly correlated
+0.70%
SMMNY - EKTAY
29%
Poorly correlated
+0.13%
PHG - EKTAY
29%
Poorly correlated
-0.04%
GNGBY - EKTAY
26%
Poorly correlated
-0.47%
NEOG - EKTAY
26%
Poorly correlated
+5.45%
More

PHG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHG
1D Price
Change %
PHG100%
-0.04%
RYLPF - PHG
56%
Loosely correlated
N/A
ALC - PHG
40%
Loosely correlated
+0.31%
BAX - PHG
40%
Loosely correlated
+1.83%
MMSI - PHG
38%
Loosely correlated
+1.03%
ATR - PHG
37%
Loosely correlated
-0.41%
More